Scholar IQ
Try ScholarIQ free
About the database
ScholarIQanswers from OpenAlex

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty

PaperCitations, authors & open-access status

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty have?

ScholarIQcitation count

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty has 108 citations in the OpenAlex counts ScholarIQ stores.

When was Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty published?

ScholarIQyear

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty has 2017 year in the ScholarIQ index.

What is the open-access status of Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty?

ScholarIQoa status

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty has hybrid oa status in the ScholarIQ index.

What is the DOI of Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty?

ScholarIQdoi

The DOI for Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty is on the source record.

What is the PMID of Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty?

ScholarIQpmid

The PMID for Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty is on the source record.

What is the OpenAlex record for Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty?

ScholarIQopenalex

The OpenAlex for Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty is on the source record.

Related on ScholarIQ

Bradley J. Goldstein
Author
The Journals of Gerontology Series A
Journal
Mesenchymal stem cell research
Topic
Mesenchymal stem cell research
Topic
Frailty in Older Adults
Topic
Telomeres, Telomerase, and Senescence
Topic
470M+ articles · 14-day free trial